Rigorous Trial Design Is Essential to Understand the Role of Opioid Receptors in Ketamine's Antidepressant Effect-Reply
JAMA Psychiatry
.
2019 Jun 1;76(6):658-659.
doi: 10.1001/jamapsychiatry.2019.0763.
Authors
John H Krystal
1
,
Gihyun Yoon
1
,
Ismene L Petrakis
1
Affiliation
1
Department of Psychiatry, Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut.
PMID:
31042270
DOI:
10.1001/jamapsychiatry.2019.0763
No abstract available
Publication types
Letter
Comment
MeSH terms
Alcoholism*
Antidepressive Agents
Depression
Humans
Ketamine*
Naltrexone
Receptors, Opioid
Substances
Antidepressive Agents
Receptors, Opioid
Naltrexone
Ketamine